Logo
x

Search

Subscribe Now

Provention Bio

Provention Bio's TZIELD (teplizumab-mzwv) Receives the US FDA's Approval of BLA for the Treatment of Stage 2 Type 1 Diabetes

Provention Bio's TZIELD (teplizumab-mzwv) Receives the US FDA's Approval of BLA for the Treatment of Stage 2 Type 1 Diabetes

  • November 21, 2022
Provention Bio Initiates P-IIa (PREVAIL-2) Study of PRV-3279 for the Treatment of Systemic Lupus Erythematosus

Provention Bio Initiates P-IIa (PREVAIL-2) Study of PRV-3279 for the Treatment of Systemic Lupus Erythematosus

  • January 21, 2022
PharmaShots Weekly Snapshots (May 24 - 28, 2021)

PharmaShots Weekly Snapshots (May 24 - 28, 2021)

  • May 28, 2021
PharmaShots Weekly Snapshot (January 4-8, 2020)

PharmaShots Weekly Snapshot (January 4-8, 2020)

  • January 8, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.